HB 0229 2003
1	CHAMBER ACTION
2
3
4
5
6	The Committee on Future of Florida's Families recommends the
7	following:
8
9	Committee Substitute
10	Remove the entire bill and insert:
11	A bill to be entitled
12	An act relating to developmental disabilities; amending s.
13	409.912, F.S.; requiring the Agency for Health Care
14	Administration to develop a model waiver program for
15	children with specified disorders; providing for
16	implementation subject to the availability of funds;
17	providing an effective date.
18
19	Be It Enacted by the Legislature of the State of Florida:
20
21	Section 1. Subsection (41) is added to section 409.912,
22	Florida Statutes, to read:
23	409.912 Cost-effective purchasing of health care.--The
24	agency shall purchase goods and services for Medicaid recipients
25	in the most cost-effective manner consistent with the delivery
26	of quality medical care. The agency shall maximize the use of
27	prepaid per capita and prepaid aggregate fixed-sum basis
28	services when appropriate and other alternative service delivery
29	and reimbursement methodologies, including competitive bidding
30	pursuant to s. 287.057, designed to facilitate the cost-
31	effective purchase of a case-managed continuum of care. The
32	agency shall also require providers to minimize the exposure of
33	recipients to the need for acute inpatient, custodial, and other
34	institutional care and the inappropriate or unnecessary use of
35	high-cost services. The agency may establish prior authorization
36	requirements for certain populations of Medicaid beneficiaries,
37	certain drug classes, or particular drugs to prevent fraud,
38	abuse, overuse, and possible dangerous drug interactions. The
39	Pharmaceutical and Therapeutics Committee shall make
40	recommendations to the agency on drugs for which prior
41	authorization is required. The agency shall inform the
42	Pharmaceutical and Therapeutics Committee of its decisions
43	regarding drugs subject to prior authorization.
44	(41) The agency shall work with the Department of Children
45	and Family Services to develop a model home and community-based
46	waiver to serve children who are diagnosed with familial
47	dysautonomia or Riley-Day syndrome caused by a mutation of the
48	IKBKAP gene on chromosome 9. The agency shall seek federal
49	waiver approval and implement the approved waiver subject to the
50	availability of funds and any limitations provided in the
51	General Appropriations Act. The agency may adopt rules to
52	implement this waiver program.
53	Section 2. This act shall take effect July 1, 2003.